• Inside Labour

    Without radical policy change SA's social fabric will continue to fray, says Terry Bell.

  • Long live your gadget

    Real gadget protection tends to cost real money, writes Arthur Goldstuck.

  • Taking SA for a ride

    The ANC seems to think all South Africans are idiots, says Mzwandile Jacks.

Data provided by iNet BFA
Loading...
See More

Mediclinic eyes R5bn in rights offer

Aug 01 2012 08:50 I-Net Bridge

Company Data

REMGRO LIMITED [JSE:REM]

Last traded 243.63
Change -0.69
% Change 0.00
Cumulative volume 1297102
Market cap 117.21bn

Last Updated: 29/08/2014 at 04:27. Prices are delayed by 15 minutes. Source: McGregor BFA

MEDICLINIC INTERNATIONAL LIMITED [JSE:MDC]

Last traded 92.63
Change 0.24
% Change 0.00
Cumulative volume 664231
Market cap 80.40bn

Last Updated: 29/08/2014 at 04:27. Prices are delayed by 15 minutes. Source: McGregor BFA

Related Articles

Mediclinic boasts 10.7% rise in H1 profit

Mediclinic firmly behind NHI

Mediclinic rejects pricing criticism

Medi-Clinic’s Swiss roll-out

Medi-Clinic spends big in SA

Medi-Clinic full-year profit flat

 

Johannesburg - South African private hospital group Mediclinic Corporation [JSE:MDC] said on Wednesday it plans to raise R5bn through a rights offer to refinance debt and to fund expansion.

Mediclinic, which operates hospitals in South Africa, Switzerland and the United Arab Emirates, said it would issue 174.6 million new shares at R28.63 per share.

That represents a 25% discount to the stock’s 30-day volume weighted average price.

Existing shareholders will be able to purchase 26.8 new shares for every 100 held.

Mediclinic said the proceeds would be used to refinance its existing debt of about R28bn, which is denominated in both the South African rand and the Swiss franc.

“The refinancing provides the group with the appropriate capital structure to pursue strategic growth and development opportunities, while significantly reducing financing costs,” it said in a statement. 

The rights offer is fully underwritten by Remgro [JSE:REM].

Among the conditions for the deal is approval from Mediclinic shareholders.

Shares of Mediclinic are up 16% so far this year, outperforming an 8.2% rise in Johannesburg’s All Share [JSE:J203] index.


 
mediclinic
NEXT ON FIN24X

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

We're talking about:

Small Business

“Hippie sense makes business sense,” an entrepreneur said, adding that "purpose" was core to success.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...
Loading...